Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias (AJUAR)
Sponsor: Hospital Clinic of Barcelona
This PHASE4 trial investigates Atrial Fibrillation and Brugada Syndrome and is currently completed. Hospital Clinic of Barcelona leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Jun 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital Clinic of Barcelona
For direct contact, visit the study record on ClinicalTrials.gov .